(Reuters) -Mirati Therapeutics said on Friday the European Medicines Agency s panel had declined to back authorization for its drug to treat a type of lung .
On Friday, New London resident Mariana Vega laughed off a check for 74 cents she said she received from the state for money she was owed but didn’t know existed.
“I’m like, why did they even send this.
Operator: Good afternoon, and welcome to the Mirati Therapeutics First Quarter 2023 Earnings Call. My name is Justin, and I will be the operator for today’s call.